These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28411071)

  • 1. Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.
    Abel EJ; Masterson TA; Karam JA; Master VA; Margulis V; Hutchinson R; Lorentz CA; Bloom E; Bauman TM; Wood CG; Blute ML
    J Urol; 2017 Oct; 198(4):810-816. PubMed ID: 28411071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
    Abel EJ; Spiess PE; Margulis V; Master VA; Mann M; Zargar-Shoshtari K; Borregales LD; Sexton WJ; Patil D; Matin SF; Wood CG; Karam JA
    J Urol; 2017 Aug; 198(2):281-288. PubMed ID: 28268170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system.
    Cho MC; Kim JK; Moon KC; Kim HH; Kwak C
    Int Braz J Urol; 2013; 39(3):353-63. PubMed ID: 23849567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal of post-operative nomogram for overall survival in patients with renal cell carcinoma and venous tumor thrombus.
    Gu L; Wang Z; Chen L; Ma X; Li H; Nie W; Peng C; Li X; Gao Y; Zhang X
    J Surg Oncol; 2017 Jun; 115(7):905-912. PubMed ID: 28230236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.
    Morshaeuser L; May M; Burger M; Otto W; Hutterer GC; Pichler M; Klatte T; Wild P; Buser L; Brookman-May S
    Urol Oncol; 2018 Mar; 36(3):94.e15-94.e21. PubMed ID: 29221641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.
    Zini L; Destrieux-Garnier L; Leroy X; Villers A; Haulon S; Lemaitre L; Koussa M
    J Urol; 2008 Feb; 179(2):450-4; discussion 454. PubMed ID: 18076946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients.
    Hupertan V; Roupret M; Poisson JF; Chretien Y; Dufour B; Thiounn N; Mejean A
    Cancer; 2006 Dec; 107(11):2604-8. PubMed ID: 17075871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for recurrence in pT3aN0M0 renal cell carcinoma according to 2009 TNM classification].
    Utsunomiya N; Kono Y; Matsumoto K; Sumiyoshi T; Masuda N; Shiraishi Y; Negoro H; Tsunemori H; Sugino Y; Okubo K; Okada T; Segawa T; Muguruma K; Kawakita M
    Hinyokika Kiyo; 2014 Jan; 60(1):1-5. PubMed ID: 24594765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus.
    Abel EJ; Wood CG; Eickstaedt N; Fang JE; Kenney P; Bagrodia A; Youssef RF; Sagalowsky AI; Margulis V
    J Urol; 2013 Aug; 190(2):452-7. PubMed ID: 23434945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus.
    Ihaddadene R; Yokom DW; Le Gal G; Moretto P; Canil CM; Delluc A; Reaume N; Carrier M
    J Thromb Haemost; 2014 Jun; 12(6):855-9. PubMed ID: 24702743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
    Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
    Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nomogram to predict recurrence for clinical T1/2 clear cell renal cell carcinoma patients after nephrectomy.
    Wang K; Guo B; Niu Y; Li G
    BMC Surg; 2024 Jun; 24(1):196. PubMed ID: 38926690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
    Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
    Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
    Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
    Int J Urol; 2015 Mar; 22(3):264-70. PubMed ID: 25428139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
    Klatte T; Remzi M; Zigeuner RE; Mannweiler S; Said JW; Kabbinavar FF; Haitel A; Waldert M; de Martino M; Marberger M; Belldegrun AS; Pantuck AJ
    J Urol; 2010 Jul; 184(1):53-8. PubMed ID: 20478577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.